메뉴 건너뛰기




Volumn 21, Issue 9, 2014, Pages 911-916

Why the product labeling for low-dose vaginal estrogen should be changed

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN;

EID: 84906937868     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/GME.0000000000000316     Document Type: Review
Times cited : (61)

References (46)
  • 1
    • 84883608600 scopus 로고    scopus 로고
    • Management of symptomatic vulvovaginal atrophy: 2013 position statement of the North American Menopause Society
    • The North American Menopause Society
    • The North American Menopause Society. Management of symptomatic vulvovaginal atrophy: 2013 position statement of The North American Menopause Society. Menopause 2013;20:888-902.
    • (2013) Menopause , vol.20 , pp. 888-902
  • 2
    • 0037125379 scopus 로고    scopus 로고
    • Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial
    • Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-333.
    • (2002) JAMA , vol.288 , pp. 321-333
    • Rossouw, J.E.1    Anderson, G.L.2    Prentice, R.L.3
  • 3
    • 0346599193 scopus 로고    scopus 로고
    • National use of postmenopausal hormone therapy: Annual trends and response to recent evidence
    • Hersh AL, Stefanick ML, Stafford RS. National use of postmenopausal hormone therapy: annual trends and response to recent evidence. JAMA 2004;291:47-53.
    • (2004) JAMA , vol.291 , pp. 47-53
    • Hersh, A.L.1    Stefanick, M.L.2    Stafford, R.S.3
  • 5
    • 68349155731 scopus 로고    scopus 로고
    • Prevalence and impact of vaginal symptoms among postmenopausal women
    • Santoro N, Komi J. Prevalence and impact of vaginal symptoms among postmenopausal women. J Sex Med 2009;6:2133-2142.
    • (2009) J Sex Med , vol.6 , pp. 2133-2142
    • Santoro, N.1    Komi, J.2
  • 6
    • 84860321813 scopus 로고    scopus 로고
    • Vaginal health: Insights, views & attitudes (VIVA)-results from an international survey
    • Nappi RE, Kokot-Kierepa M. Vaginal Health: Insights, Views & Attitudes (VIVA)-results from an international survey. Climacteric 2012;15:36-44.
    • (2012) Climacteric , vol.15 , pp. 36-44
    • Nappi, R.E.1    Kokot-Kierepa, M.2
  • 7
    • 84879837382 scopus 로고    scopus 로고
    • Vulvar and vaginal atrophy in postmenopausal women: Findings from the REVIVE (Real Women's Views of Treatment Options for Menopausal Vaginal Changes) survey [published online ahead of print May 16, 2013]
    • Kingsberg SA, Wysocki S, Magnus L, Krychman ML. Vulvar and vaginal atrophy in postmenopausal women: findings from the REVIVE (Real Women's Views of Treatment Options for Menopausal Vaginal Changes) survey [published online ahead of print May 16, 2013]. J Sex Med 2013;10:1790-1799.
    • (2013) J Sex Med , vol.10 , pp. 1790-1799
    • Kingsberg, S.A.1    Wysocki, S.2    Magnus, L.3    Krychman, M.L.4
  • 8
    • 77949915102 scopus 로고    scopus 로고
    • The incidence of urinary incontinence across Asian, black, and white women in the United States
    • Townsend MK, Curhan GC, Resnick NM, Grodstein F. The incidence of urinary incontinence across Asian, black, and white women in the United States. Am J Obstet Gynecol 2010;202:378.e1-378.e7.
    • (2010) Am J Obstet Gynecol , vol.202
    • Townsend, M.K.1    Curhan, G.C.2    Resnick, N.M.3    Grodstein, F.4
  • 9
    • 33748951949 scopus 로고    scopus 로고
    • A randomized comparative study of the effects of oral and topical estrogen therapy on the vaginal vascularization and sexual function in hysterectomized postmenopausal women
    • Long CY, Liu CM, Hsu SC, Wu CH, Wang CL, Tsai EM. A randomized comparative study of the effects of oral and topical estrogen therapy on the vaginal vascularization and sexual function in hysterectomized postmenopausal women. Menopause 2006;13:737-743.
    • (2006) Menopause , vol.13 , pp. 737-743
    • Long, C.Y.1    Liu, C.M.2    Hsu, S.C.3    Wu, C.H.4    Wang, C.L.5    Tsai, E.M.6
  • 10
    • 0031716329 scopus 로고    scopus 로고
    • Metaanalysis of estrogen therapy in the management of urogenital atrophy in postmenopausal women: Second report of the Hormones and Urogenital Therapy Committee
    • Cardozo L, Bachmann G, McClish D, Fonda D, Birgerson L. Metaanalysis of estrogen therapy in the management of urogenital atrophy in postmenopausal women: second report of the Hormones and Urogenital Therapy Committee. Obstet Gynecol 1998;92(pt 2):722-727.
    • (1998) Obstet Gynecol , vol.92 , Issue.PART 2 , pp. 722-727
    • Cardozo, L.1    Bachmann, G.2    McClish, D.3    Fonda, D.4    Birgerson, L.5
  • 12
    • 0027296111 scopus 로고
    • A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections
    • Raz R, Stamm WE. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med 1993;329:753-757.
    • (1993) N Engl J Med , vol.329 , pp. 753-757
    • Raz, R.1    Stamm, W.E.2
  • 13
    • 0033002046 scopus 로고    scopus 로고
    • A randomized, open, parallel-group study on the preventive effect of an estradiol-releasing vaginal ring (Estring) on recurrent urinary tract infection in post-menopausal women
    • Eriksen B. A randomized, open, parallel-group study on the preventive effect of an estradiol-releasing vaginal ring (Estring) on recurrent urinary tract infection in post-menopausal women. Am J Obstet Gynecol 1999;180:1072-1079.
    • (1999) Am J Obstet Gynecol , vol.180 , pp. 1072-1079
    • Eriksen, B.1
  • 14
    • 80052422184 scopus 로고    scopus 로고
    • Randomized trial of estradiol vaginal ring versus oral oxybutynin for the treatment of overactive bladder
    • Nelken RS, Ozel BZ, Leegant AR, Felix JC, Mishell DR Jr. Randomized trial of estradiol vaginal ring versus oral oxybutynin for the treatment of overactive bladder. Menopause 2011;18:962-966.
    • (2011) Menopause , vol.18 , pp. 962-966
    • Nelken, R.S.1    Ozel, B.Z.2    Leegant, A.R.3    Felix, J.C.4    Mishell Jr., D.R.5
  • 16
    • 0035162035 scopus 로고    scopus 로고
    • Postmenopausal hormones and incontinence: The Heart and Estrogen/Progestin Replacement Study
    • HERS Research Group
    • Grady D, Brown JS, Vittinghoff E, Applegate W, Varner E, Snyder T; HERS Research Group. Postmenopausal hormones and incontinence: the Heart and Estrogen/Progestin Replacement Study. Obstet Gynecol 2001;97:116-120.
    • (2001) Obstet Gynecol , vol.97 , pp. 116-120
    • Grady, D.1    Brown, J.S.2    Vittinghoff, E.3    Applegate, W.4    Varner, E.5    Snyder, T.6
  • 17
    • 84937934020 scopus 로고    scopus 로고
    • (updated March 15, 2013). Accessed June 14
    • Bachman GA, Santen R Treatment of vaginal atrophy up to date (updated March 15, 2013). Available at: http://www.uptodate.com/contents/treatment- ofvaginal-atrophy?source=search-result&search=vaginal+atrophy& selectedTitle= 1%7E49#subscribeMessage. Accessed June 14, 2014.
    • (2014) Treatment of Vaginal Atrophy Up to Date
    • Bachman, G.A.1    Santen, R.2
  • 18
    • 33749541916 scopus 로고    scopus 로고
    • Comparison of methods to measure low serum estradiol levels in postmenopausal women
    • Lee JS, Ettinger B, Stanczyk FZ, et al. Comparison of methods to measure low serum estradiol levels in postmenopausal women. J Clin Endocrinol Metab 2006;91:3791-3797.
    • (2006) J Clin Endocrinol Metab , vol.91 , pp. 3791-3797
    • Lee, J.S.1    Ettinger, B.2    Stanczyk, F.Z.3
  • 19
    • 18744397868 scopus 로고    scopus 로고
    • Endometrial and vaginal effects of low-dose estradiol delivered by vaginal ring or vaginal tablet
    • Weisberg E, Ayton R, Darling G, et al. Endometrial and vaginal effects of low-dose estradiol delivered by vaginal ring or vaginal tablet. Climacteric 2005;8:83-92.
    • (2005) Climacteric , vol.8 , pp. 83-92
    • Weisberg, E.1    Ayton, R.2    Darling, G.3
  • 21
    • 0036583220 scopus 로고    scopus 로고
    • Endometrial thickness and uterine diameter not affected by ultralow doses of 17β-estradiol in elderly women
    • Naessen T, Rodriguez-Macias K. Endometrial thickness and uterine diameter not affected by ultralow doses of 17β-estradiol in elderly women. Am J Obstet Gynecol 2002;186:944-947.
    • (2002) Am J Obstet Gynecol , vol.186 , pp. 944-947
    • Naessen, T.1    Rodriguez-Macias, K.2
  • 22
    • 0036244574 scopus 로고    scopus 로고
    • Treatment of urogenital atrophy with low-dose estradiol: Preliminary results
    • Santen RJ, Pinkerton JV, Conaway M, et al. Treatment of urogenital atrophy with low-dose estradiol: preliminary results. Menopause 2002;9:179-187.
    • (2002) Menopause , vol.9 , pp. 179-187
    • Santen, R.J.1    Pinkerton, J.V.2    Conaway, M.3
  • 23
    • 77951782692 scopus 로고    scopus 로고
    • Minimized estradiol absorption with ultra-low-dose 10 μg 17β-estradiol vaginal tablets
    • Eugster-Hausmann M, Waitzinger J, Lehnick D. Minimized estradiol absorption with ultra-low-dose 10 μg 17β-estradiol vaginal tablets. Climacteric 2010;13:219-227.
    • (2010) Climacteric , vol.13 , pp. 219-227
    • Eugster-Hausmann, M.1    Waitzinger, J.2    Lehnick, D.3
  • 24
    • 0017796942 scopus 로고
    • Absorption of estrogens from vaginal creams
    • Rigg LA, Hermann H, Yen SS. Absorption of estrogens from vaginal creams. N Engl J Med 1978;298:195-197.
    • (1978) N Engl J Med , vol.298 , pp. 195-197
    • Rigg, L.A.1    Hermann, H.2    Yen, S.S.3
  • 25
    • 0028129192 scopus 로고
    • Vaginal administration of low-dose conjugated estrogens: Systemic absorption and effects on the endometrium
    • Handa VL, Bachus KE, Johnston WW, Robboy SJ, Hammond CB. Vaginal administration of low-dose conjugated estrogens: systemic absorption and effects on the endometrium. Obstet Gynecol 1994;84:215-218.
    • (1994) Obstet Gynecol , vol.84 , pp. 215-218
    • Handa, V.L.1    Bachus, K.E.2    Johnston, W.W.3    Robboy, S.J.4    Hammond, C.B.5
  • 26
    • 10944236220 scopus 로고    scopus 로고
    • The menopausal transition: A 9-year prospective population-based study. The Melbourne Women's Midlife Health Project
    • Guthrie JR, Dennerstein L, Taffe JR, Lehert P, Burger HG. The menopausal transition: a 9-year prospective population-based study. The Melbourne Women's Midlife Health Project. Climacteric 2004;7:375-389.
    • (2004) Climacteric , vol.7 , pp. 375-389
    • Guthrie, J.R.1    Dennerstein, L.2    Taffe, J.R.3    Lehert, P.4    Burger, H.G.5
  • 27
    • 22744439543 scopus 로고    scopus 로고
    • Serum estradiol level in Thai surgical menopausal women receiving oral micronized 17β-estradiol 1 mg
    • Veeranarapanich S, Bunyavejchevin S, Lumlertkittikul S. Serum estradiol level in Thai surgical menopausal women receiving oral micronized 17β-estradiol 1 mg. J Med Assoc Thai 2004:S1-S4.
    • (2004) J Med Assoc Thai
    • Veeranarapanich, S.1    Bunyavejchevin, S.2    Lumlertkittikul, S.3
  • 28
    • 84907348536 scopus 로고    scopus 로고
    • Arterial imaging outcomes and cardiovascular risk factors in recently menopausal women in the Kronos Early Estrogen Prevention Study (KEEPS): A randomized controlled trial
    • [published online ahead of print July 29, 2014]. doi:10.7326/M14-0353. Accessed July 29
    • Harman SM, Black DM, Naftolin F, et al. Arterial imaging outcomes and cardiovascular risk factors in recently menopausal women in the Kronos Early Estrogen Prevention Study (KEEPS): a randomized controlled trial. [published online ahead of print July 29, 2014]. Ann Intern Med. doi:10.7326/M14-0353. http://annals.org/article.aspx?articleid=1891628. Accessed July 29, 2014.
    • (2014) Ann Intern Med.
    • Harman, S.M.1    Black, D.M.2    Naftolin, F.3
  • 30
    • 84906940424 scopus 로고    scopus 로고
    • Vagifem [package label]. Accessed July 25
    • Vagifem [package label]. Available at: http://www.mhra.gov.uk/home/ groups/par/documents/websiteresources/con078939.pdf. Accessed July 25, 2014.
    • (2014)
  • 31
    • 34447259105 scopus 로고    scopus 로고
    • Effect of ultra-low-dose transdermal estradiol on breast density in postmenopausal women
    • Grady D, Vittinghoff E, Lin F, et al. Effect of ultra-low-dose transdermal estradiol on breast density in postmenopausal women. Menopause 2007; 14(pt 1):391-396.
    • (2007) Menopause , vol.14 , Issue.PART 1 , pp. 391-396
    • Grady, D.1    Vittinghoff, E.2    Lin, F.3
  • 32
    • 33845383231 scopus 로고    scopus 로고
    • Breast cancer risk in postmenopausal women using estrogen-only therapy
    • Lyytinen H, Pukkala E, Ylikorkala O. Breast cancer risk in postmenopausal women using estrogen-only therapy. Obstet Gynecol 2006;108:1354-1360.
    • (2006) Obstet Gynecol , vol.108 , pp. 1354-1360
    • Lyytinen, H.1    Pukkala, E.2    Ylikorkala, O.3
  • 33
    • 84860474009 scopus 로고    scopus 로고
    • Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: Extended follow-up of the Women's Health Initiative randomised placebo-controlled trial
    • Anderson GL, Chlebowski RT, Aragaki AK, et al. Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial. Lancet Oncol 2012;13:476-486.
    • (2012) Lancet Oncol , vol.13 , pp. 476-486
    • Anderson, G.L.1    Chlebowski, R.T.2    Aragaki, A.K.3
  • 34
    • 84884917272 scopus 로고    scopus 로고
    • Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials
    • Manson JE, Chlebowski RT, Stefanick ML, et al. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials. JAMA 2013;310:1353-1368.
    • (2013) JAMA , vol.310 , pp. 1353-1368
    • Manson, J.E.1    Chlebowski, R.T.2    Stefanick, M.L.3
  • 35
    • 84880313521 scopus 로고    scopus 로고
    • Ultra-low-dose vaginal estrogen tablets for the treatment of postmenopausal vaginal atrophy
    • Simon JA, Maamari RV. Ultra-low-dose vaginal estrogen tablets for the treatment of postmenopausal vaginal atrophy. Climacteric 2013; 16(suppl 1):37-43.
    • (2013) Climacteric , vol.16 , Issue.SUPPL. 1 , pp. 37-43
    • Simon, J.A.1    Maamari, R.V.2
  • 36
    • 77952168220 scopus 로고    scopus 로고
    • Low-dose vaginal estrogens or vaginal moisturizer in breast cancer survivors with urogenital atrophy: A preliminary study
    • Biglia N, Peano E, Sgandurra P, et al. Low-dose vaginal estrogens or vaginal moisturizer in breast cancer survivors with urogenital atrophy: a preliminary study. Gynecol Endocrinol 2010;26:404-412.
    • (2010) Gynecol Endocrinol , vol.26 , pp. 404-412
    • Biglia, N.1    Peano, E.2    Sgandurra, P.3
  • 37
    • 33645292020 scopus 로고    scopus 로고
    • Caution: Vaginal estradiol appears to be contraindicated in postmenopausal women on adjuvant aromatase inhibitors
    • Kendall A, Dowsett M, Folkerd E, Smith I. Caution: vaginal estradiol appears to be contraindicated in postmenopausal women on adjuvant aromatase inhibitors. Ann Oncol 2006;17:584-587.
    • (2006) Ann Oncol , vol.17 , pp. 584-587
    • Kendall, A.1    Dowsett, M.2    Folkerd, E.3    Smith, I.4
  • 38
    • 84866542410 scopus 로고    scopus 로고
    • Local estrogen therapy and risk of breast cancer recurrence among hormonetreated patients: A nested case-control study
    • Le Ray I, Dell'Aniello S, Bonnetain F, Azoulay L, Suissa S. Local estrogen therapy and risk of breast cancer recurrence among hormonetreated patients: a nested case-control study. Breast Cancer Res Treat 2012;135:603-609.
    • (2012) Breast Cancer Res Treat , vol.135 , pp. 603-609
    • Le Ray, I.1    Dell'Aniello, S.2    Bonnetain, F.3    Azoulay, L.4    Suissa, S.5
  • 39
    • 84867904099 scopus 로고    scopus 로고
    • Effects of vaginal estrogens on serum estradiol levels in postmenopausal breast cancer survivors and women at risk of breast cancer taking an aromatase inhibitor or a selective estrogen receptor modulator
    • Wills S, Ravipati A, Venuturumilli P, et al. Effects of vaginal estrogens on serum estradiol levels in postmenopausal breast cancer survivors and women at risk of breast cancer taking an aromatase inhibitor or a selective estrogen receptor modulator. J Oncol Pract 2012;8:144-148.
    • (2012) J Oncol Pract , vol.8 , pp. 144-148
    • Wills, S.1    Ravipati, A.2    Venuturumilli, P.3
  • 40
    • 21044435024 scopus 로고    scopus 로고
    • Menopausal hormone therapy after breast cancer: A meta-analysis and critical appraisal of the evidence
    • Col NF, Kim JA, Chleboskwi RT. Menopausal hormone therapy after breast cancer: a meta-analysis and critical appraisal of the evidence. Breast Cancer Res 2005;7:R535-R540.
    • (2005) Breast Cancer Res , vol.7
    • Col, N.F.1    Kim, J.A.2    Chleboskwi, R.T.3
  • 41
    • 74549190931 scopus 로고    scopus 로고
    • Efficacy and tolerability of local estrogen therapy for urogenital atrophy
    • Archer DF. Efficacy and tolerability of local estrogen therapy for urogenital atrophy. Menopause 2010;17:194-203.
    • (2010) Menopause , vol.17 , pp. 194-203
    • Archer, D.F.1
  • 42
    • 33847116637 scopus 로고    scopus 로고
    • Hormone therapy and venous thromboembolism among postmenopausal women: Impact of the route of estrogen administration and progestins
    • Canonico M, Oger E, Plu-Bureau G, et al. Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestins. Circulation 2007;115:840-845.
    • (2007) Circulation , vol.115 , pp. 840-845
    • Canonico, M.1    Oger, E.2    Plu-Bureau, G.3
  • 43
    • 84857508749 scopus 로고    scopus 로고
    • The 2012 hormone therapy position statement of the North American Menopause Society
    • The North American Menopause Society
    • The North American Menopause Society. The 2012 hormone therapy position statement of The North American Menopause Society. Menopause 2012;19:257-271.
    • (2012) Menopause , vol.19 , pp. 257-271
  • 44
    • 79953743574 scopus 로고    scopus 로고
    • Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: A randomized controlled trial
    • LaCroix AZ, Chlebowski RT, Manson JE, et al. Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial. JAMA 2011;305: 1305-1314.
    • (2011) JAMA , vol.305 , pp. 1305-1314
    • Lacroix, A.Z.1    Chlebowski, R.T.2    Manson, J.E.3
  • 45
    • 75949102926 scopus 로고    scopus 로고
    • Biological mechanisms linking obesity and cancer risk: New perspectives
    • Roberts DL, Dive C, Renehan AG. Biological mechanisms linking obesity and cancer risk: new perspectives. Annu Rev Med 2010;61: 301-316.
    • (2010) Annu Rev Med , vol.61 , pp. 301-316
    • Roberts, D.L.1    Dive, C.2    Renehan, A.G.3
  • 46
    • 33845866857 scopus 로고    scopus 로고
    • Inflammation and metabolic disorders
    • Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006; 444:860-867.
    • (2006) Nature , vol.444 , pp. 860-867
    • Hotamisligil, G.S.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.